Safety, Immunogenicity and Reactogenicity Trial of Mencevax ACW135 Vaccine

Clinical trial NCT00994695 · COMPLETED

Trial details

NCT number: NCT00994695
Sponsor: Armauer Hansen Research Institute, Ethiopia
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Meningococcal Meningitis

Start date: 2005-11-01
Primary completion: 2006-01-01
Enrollment: 412

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.